CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Konidaris Tasos Executive Vice President & CFO | Option exercise · Performance-Based Restricted Stock Units | −181,159 | 0 | ||
| 2025-03-03 | Konidaris Tasos Executive Vice President & CFO | Grant or award · Performance-Based Restricted Stock Units | +228,310 | 228,310 | ||
| 2025-03-03 | Konidaris Tasos Executive Vice President & CFO | Grant or award · Restricted Stock Units | +114,155 | 114,154 | ||
| 2025-03-03 | Patel Chirag K. President & Co-CEO | Option exercise | +579,710 | 1,092,276 | ||
| 2025-03-03 | Patel Chirag K. President & Co-CEO | Shares withheld for taxes | −279,527 | $8.76 | $2.4M | 812,749 |
| 2025-03-03 | Patel Chirag K. President & Co-CEO | Option exercise · Performance-Based Restricted Stock Units | −579,710 | 0 | ||
| 2025-03-03 | Patel Chirag K. President & Co-CEO | Grant or award · Performance-Based Restricted Stock Units | +890,410 | 890,410 | ||
| 2025-03-03 | Patel Chirag K. President & Co-CEO | Grant or award · Restricted Stock Units | +239,726 | 239,726 | ||
| 2025-03-03 | Patel Chintu Co-CEO | Option exercise | +579,710 | 1,092,276 | ||
| 2025-03-03 | Patel Chintu Co-CEO | Shares withheld for taxes | −274,307 | $8.76 | $2.4M | 817,969 |
| 2025-03-03 | Patel Chintu Co-CEO | Option exercise · Performance-Based Restricted Stock Units | −579,710 | 0 | ||
| 2025-03-03 | Patel Chintu Co-CEO | Grant or award · Performance-Based Restricted Stock Units | +890,410 | 890,410 | ||
| 2025-03-03 | Patel Chintu Co-CEO | Grant or award · Restricted Stock Units | +239,726 | 239,726 | ||
| 2025-03-03 | Patel Gautam Director | Sale | −80,000 | $8.90 | $712K | 1,808,886 |
| 2025-03-03 | Shah Nikita Executive Vice President | Option exercise | +36,232 | 345,871 | ||
| 2025-03-03 | Shah Nikita Executive Vice President | Shares withheld for taxes | −18,533 | $8.76 | $162K | 327,338 |
| 2025-03-03 | Shah Nikita Executive Vice President | Option exercise | +45,872 | 373,210 | ||
| 2025-03-03 | Shah Nikita Executive Vice President | Shares withheld for taxes | −23,464 | $8.76 | $206K | 349,746 |
| 2025-03-03 | Shah Nikita Executive Vice President | Option exercise | +144,928 | 494,674 | ||
| 2025-03-03 | Shah Nikita Executive Vice President | Shares withheld for taxes | −74,131 | $8.76 | $649K | 420,543 |
Page 13 of 31 · 617 trades